You probably don’t know this, but your tax dollars have been used by the National Institutes of Health (NIH) to create “humanized mice” implanted with tissues taken from aborted babies.
As CNS News reports, a scientist attending “The New Humanized Rodent Model Workshop” sponsored by NIH in 2007, described the “SCID-hu Thy/Liv mouse model.” According to the AIDS Research and Therapy journal’s summary, the mouse was constructed with “human fetal liver and thymus (20-24 g.w.).” As CNS explains, “It was ‘humanized’ with organs taken from babies five to six months after conception.” The summary continued, “A single donor (one baby) provides sufficient tissue to implant 50-60 mice.”
In 2014, NIH employees described their new “humanized mouse,” the “TKO-BLT”:
Triple Knock Out (TKO) mice that are bone marrow, liver, thymus (BLT)-humanized become highly reconstituted with human immune cells and tissues.
The newer mouse used organs from babies in a slightly younger age range than the babies described at the 2007 NIH workshop.
The 2014 description continued, “Seventeen to 22 week gestational tissues … were prepared in a biological safety hood by cutting the tissues into 1-2mm³ pieces and placing them in a covered petri dish on ice in matrigel. … The tissues were divided to give the surgeons approximately the same amount of liver tissue as thymus. … Tissue was transplanted under a single kidney for each animal.”
In late 2016, the Select Investigative Panel on Infant Lives reported about the harvesting of fetal tissues at abortion clinics to make a “humanized mouse.” It wrote, “In the most extreme example of this research model, human fetal progenitors from blood, liver, and thymus are used to create a ‘BLT’ mouse that reconstitutes many aspects of the immature human immune system.”
A Harvard University backgrounder has stated that fetal tissue researchers preferred using tissue from aborted babies rather than from miscarriages, writing:
Almost all miscarriages happen at home or in locations in which fetal material is not recovered and, importantly, preserved in a usable state. Just as obtaining tissue during a scheduled surgery or an in-hospital autopsy soon after death provides tissue that is untainted by decay relative to obtaining those same tissues from the morgue or a funeral home, obtaining fetal material from elective pregnancy termination is far superior to obtaining whatever material might be recoverable following spontaneous miscarriage, even assuming a mechanism existed for the collection of such material.
NIH admits it spent $67 million on human fetal tissue research in fiscal 2013; $76 million in fiscal 2014; $80 million in fiscal 2015; $103 million in fiscal 2016; and $107 million in fiscal 2017.